Yaneva Zvezdelina, Ivanova Donika
Chemistry Unit, Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Trakia University, Students Campus, 6000 Stara Zagora, Bulgaria.
Antioxidants (Basel). 2020 Nov 26;9(12):1180. doi: 10.3390/antiox9121180.
Epidemiological studies and clinical investigations proposed that catechins extracts alone may not provide a sufficient level of bioactivities and promising therapeutic effects to achieve health benefits due to a number of constraints related to poor oral absorption, limited bioavailability, sensitivity to oxidation, etc. Modern scientific studies have reported numerous techniques for the design of micro- and nano-bio-delivery systems as novel and promising strategies to overcome these obstacles and to enhance catechins' therapeutic activity. The objective assessment of their benefits, however, requires a critical comparative estimation of the advantages and disadvantages of the designed catechins-biocarrier systems, their biological activities and safety administration aspects. In this respect, the present review objectively outlines, compares and assesses the recent advances related to newly developed design concepts of catechins' encapsulation into various biopolymer carriers and their release behaviour, with a special emphasis on the specific physiological biofunctionalities of the innovative bioflavonoid/biopolymer delivery systems.
流行病学研究和临床调查表明,由于存在口服吸收差、生物利用度有限、对氧化敏感等诸多限制因素,单独的儿茶素提取物可能无法提供足够水平的生物活性和显著的治疗效果以实现健康益处。现代科学研究报道了许多用于设计微米和纳米生物递送系统的技术,作为克服这些障碍并增强儿茶素治疗活性的新颖且有前景的策略。然而,对其益处的客观评估需要对所设计的儿茶素 - 生物载体系统的优缺点、它们的生物活性和安全给药方面进行严格的比较评估。在这方面,本综述客观地概述、比较和评估了与儿茶素封装到各种生物聚合物载体中的新开发设计概念及其释放行为相关的最新进展,特别强调了创新型生物类黄酮/生物聚合物递送系统的特定生理生物功能。